Dual inhibition of glycolysis and autophagy as a therapeutic strategy in the treatment of Ehrlich ascites carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual inhibition of glycolysis and autophagy as a therapeutic strategy in the treatment of Ehrlich ascites carcinoma

Published:2020-03-20 Issue:7 Volume:34 Page:
ISSN:1095-6670
Container-title:Journal of Biochemical and Molecular Toxicology
language:en
Short-container-title:J Biochem Mol Toxicol

Author:

Mansour Mohammed A.¹²^ORCID,Ibrahim Wafaa M.³,Salama Mona M.¹,Salama Afrah F.¹

Affiliation:

1. Biochemistry Division, Department of Chemistry, Faculty of ScienceTanta University Tanta Egypt

2. Division of Human Sciences, School of Applied SciencesLondon South Bank University London UK

3. Medical Biochemistry Department, Faculty of MedicineTanta University Egypt

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Toxicology,Molecular Biology,Molecular Medicine,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbt.22498

Reference28 articles.

1. Targeting Cell Metabolism as Cancer Therapy

2. One-carbon metabolism for cancer diagnostic and therapeutic approaches

3. The Warburg effect: Evolving interpretations of an established concept

4. Combination of arsenic trioxide and cisplatin synergistically inhibits both hexokinase activity and viability of Ehrlich ascites carcinoma cells

5. Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to β-amyloid clearance;Nature Metabolism;2022-10-06

2. Flaxseed Ethanol Extracts’ Antitumor, Antioxidant, and Anti-Inflammatory Potential;Antioxidants;2022-04-30

3. Ethoxyquin Inhibits the Progression of Murine Ehrlich Ascites Carcinoma through the Inhibition of Autophagy and LDH;Biomedicines;2021-10-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3